巴西脏活检注册表的实施和第一份报告
Irene L Noronha1,2, Rodrigo José Ramalho1,3, Claudia Maria Costa de Oliveira1,4
1Clinical Nephrology Department of the Brazilian Society of Nephrology, São Paulo, Brazil.
PloS one
|February 10, 2025
概括
第一个巴西脏活检注册表 (BKBR) 报告揭示了巴西的关键脏疾病概况. 淋巴细胞疾病,特别是狼性炎,是最常见的,强调了针对性干预的必要性.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 活检注册表对于临床实践和卫生政策至关重要.
- 巴西脏学会于2021年建立了巴西脏活检注册表 (BKBR).
- 本报告介绍了2021年BKBR的首次数据.
研究的目的:
- 在巴西建立第一个全国性的脏活检注册.
- 分析成年原生脏活检的人口统计,临床和组织学数据.
- 了解巴西各地脏疾病的情况.
主要方法:
- 使用了巴西脏病学会网站上托管的基于网络的平台.
- 收集的数据包括患者人口统计,临床信息和组织学诊断.
- 分析包括来自巴西所有地区21个中心的954个成年原生细胞活检.
主要成果:
- 活检的主要指示是功能障碍 (56%) 和性综合征 (41.4%).
- 淋巴细胞疾病占诊断的74.8%,狼性炎 (22.6%),IgA病 (13%),焦点细分淋巴细胞硬化症 (12.2%) 是最常见的.
- 显著比例的患者 (66.2%) 降低了EGFR,尽管大多数 (60.2%) 显示轻度间歇性纤维化和管道缩.
结论:
- 这标志着巴西第一个脏活检全国性报告.
- 这些数据为巴西脏疾病的范围提供了关键的见解.
- 这些发现强调了BKBR对国家脏健康监测和战略的重要性.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Cancer Survival Analysis
862
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
862


